Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors

Abstract

Using a neutralizing monoclonal antibody specific for murine IFN gamma we show that endogenously produced IFN gamma plays an obligate role in mediating LPS-induced rejection of the Meth A fibrosarcoma tumor in syngeneic BALB/c mice. To examine the cellular targets of IFN gamma action, we generated IFN gamma-insensitive tumor cells by stably overexpressing in Meth A a truncated dominant negative form of the murine IFN gamma receptor alpha chain. When implanted in BALB/c mice, IFN gamma-insensitive Meth A cells displayed enhanced tumorigenicity compared with control Meth A cells and were not rejected when tumor-bearing mice were treated with concentrations of LPS that eliminated control tumors. In Meth A immune mice, IFN gamma-insensitive Meth A did not establish tumors while IFN gamma-insensitive tumors grew in a progressive manner. In addition, the IFN gamma-insensitive tumor cells were unable to elicit strong protective immunity to subsequent wild-type tumor challenge. These results show that IFN gamma has direct effects on tumor cell immunogenicity and thus plays an important role in promoting tumor cell recognition and elimination.

Overview

Integrity signals

Registry

Crossref · 10.1016/1074-7613(94)90087-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 663

Metadata

Authors
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D.
Affiliations
  • Washington University in St. Louis (US)
  • Ludwig Cancer Research (US)
Venue
Immunity
Publisher
Elsevier BV
Published
1994-09
Volume
1
Issue
6
Pages
447-456
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2042687451
Cited by
663
References
31
Citations by year
2026: 6 · 2025: 17 · 2024: 19 · 2023: 31 · 2022: 29 · 2021: 29 · 2020: 29 · 2019: 34 · 2018: 19 · 2017: 29 · 2016: 24 · 2015: 23 · 2014: 27 · 2013: 26 · 2012: 32
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA-43059)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords
interferon-gamma, dominant negative receptor, tumor rejection, Meth A fibrosarcoma, lipopolysaccharide, tumor immunogenicity, cancer cell detection, tumor growth, antitumor immunity, neutralizing monoclonal antibodies
MeSH terms
Interferon gamma Receptor, Animals, Female, Interferon-gamma, Lipopolysaccharides, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasm Transplantation, Neoplasms, Experimental, T-Lymphocytes, Transfection, Tumor Cells, Cultured, Mice, SCID, Interferon-alpha, Receptors, Interferon, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. https://app.cochat.ai/papers/10.1016/1074-7613(94)90087-6
The paper
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994). Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity. https://doi.org/10.1016/1074-7613(94)90087-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.